[Breaking] 'mRNA' Moderna Vaccine Passes Primary Validation... "Preventive Effect Confirmed"

[Asia Economy Reporter Chunhee Lee] The messenger ribonucleic acid (mRNA) COVID-19 vaccine developed by Moderna in the United States has been recognized for its preventive efficacy required for approval in the first expert advisory meeting held domestically.

The verification advisory group judged that, based on the results of the multinational Phase 3 clinical trials conducted in the United States, the Moderna vaccine possesses the preventive efficacy necessary for approval. They also considered the adverse events that occurred to be at an acceptable level.

This content was produced with the assistance of AI translation services.